United Kingdom · Question · Written question
UIN 76429
Obesity: Drugs
Introduced
10 September 2025
Last action
22 September 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 September 2025
Summary
To ask the Secretary of State for Health and Social Care, when he plans to expand prescribing of GLP-1 medications beyond specialist weight-management services.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 September 2025
Written question
To ask the Secretary of State for Health and Social Care, when he plans to expand prescribing of GLP-1 medications beyond specialist weight-management services.
Source: Commons
22 September 2025
Answer
National Institute for Health and Care Excellence (NICE) guidance on the first two GLP-1 medicines licensed for the treatment of obesity, namely liraglutide under various brand names and semaglutide with brand name Wegovy, restricted their use to speciali...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-10/76429
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1833938
- uk · wq-1833938 · source updated 22 September 2025